LU92749I2 - Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2) - Google Patents

Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2) Download PDF

Info

Publication number
LU92749I2
LU92749I2 LU92749C LU92749C LU92749I2 LU 92749 I2 LU92749 I2 LU 92749I2 LU 92749 C LU92749 C LU 92749C LU 92749 C LU92749 C LU 92749C LU 92749 I2 LU92749 I2 LU 92749I2
Authority
LU
Luxembourg
Prior art keywords
bvdv
diarrhea virus
bovine viral
viral diarrhea
attenuated bovine
Prior art date
Application number
LU92749C
Other languages
English (en)
French (fr)
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34967522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92749(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of LU92749I2 publication Critical patent/LU92749I2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU92749C 2004-05-19 2015-06-19 Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2) LU92749I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025452A DE102004025452A1 (de) 2004-05-19 2004-05-19 Vakzine enthaltend BVDV

Publications (1)

Publication Number Publication Date
LU92749I2 true LU92749I2 (fr) 2015-11-02

Family

ID=34967522

Family Applications (3)

Application Number Title Priority Date Filing Date
LU92747C LU92747I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée bovine atténué 1 (bvdv-1)
LU92749C LU92749I2 (fr) 2004-05-19 2015-06-19 Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2)
LU92748C LU92748I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée virale bovine atténué 2 (bvdv-2)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LU92747C LU92747I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée bovine atténué 1 (bvdv-1)

Family Applications After (1)

Application Number Title Priority Date Filing Date
LU92748C LU92748I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée virale bovine atténué 2 (bvdv-2)

Country Status (25)

Country Link
EP (1) EP1751276B9 (xx)
JP (2) JP5006782B2 (xx)
KR (1) KR100908798B1 (xx)
CN (2) CN1989240B (xx)
AR (2) AR049176A1 (xx)
AT (1) ATE420949T1 (xx)
AU (1) AU2005243488B2 (xx)
BR (1) BRPI0510396B1 (xx)
CA (1) CA2561719C (xx)
CY (4) CY1109036T1 (xx)
DE (2) DE102004025452A1 (xx)
DK (1) DK1751276T5 (xx)
ES (1) ES2321210T3 (xx)
HU (2) HUS1500033I1 (xx)
LU (3) LU92747I2 (xx)
ME (1) ME01119B (xx)
MX (1) MXPA06013298A (xx)
NL (3) NL300744I1 (xx)
NZ (1) NZ552088A (xx)
PL (1) PL1751276T3 (xx)
PT (1) PT1751276E (xx)
RS (1) RS50753B9 (xx)
SI (1) SI1751276T1 (xx)
UY (1) UY28905A1 (xx)
WO (1) WO2005111201A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
UY29915A1 (es) 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
AR062917A1 (es) * 2006-09-22 2008-12-17 Intervet Int Bv Nuevo mutante de pestivirus para uso en una vacuna.
AR069087A1 (es) 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
UY31930A (es) 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
SG10201506597RA (en) 2008-10-31 2015-10-29 Boehringer Ingelheim Vetmed Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
EP2618841B1 (en) 2010-09-21 2016-10-19 Intervet International B.V. Bvdv vaccine
JP6589159B2 (ja) * 2014-04-01 2019-10-16 共立製薬株式会社 新規ネコモルビリウイルス株、不活化ワクチン製剤、並びにネコモルビリウイルス感染症予防方法
WO2015177369A1 (en) * 2014-05-23 2015-11-26 Boehringer Ingelheim Vetmedica Gmbh Recombinant classical swine fever virus (csfv) comprising substitution in the tav epitope of the e2 protein
CN105779499B (zh) * 2016-03-23 2019-11-19 江苏科技大学 重组杆状病毒和其应用及构建该重组杆状病毒的载体
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法
CN108707190B (zh) * 2018-04-18 2021-07-13 中国科学院武汉病毒研究所 猪瘟病毒ns5b蛋白保真度突变体及其应用
CN114853912B (zh) * 2022-05-24 2023-06-13 中国农业科学院兰州兽医研究所 一种牛病毒性腹泻病毒e2-e0融合蛋白、制备方法及应用
CN115960847B (zh) * 2023-01-11 2024-06-14 青岛大学 小分子依赖的内含肽自剪接系统在制备减毒活疫苗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168942B1 (en) * 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (en) * 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
CA2363493C (en) * 2000-11-22 2006-06-06 Xuemei Cao Attenuated forms of bovine viral diarrhea virus
DE10143813A1 (de) * 2001-09-06 2003-04-10 Boehringer Ingelheim Vetmed Infektiöser Rindervirusdiarrhoe-Virusklon

Also Published As

Publication number Publication date
MXPA06013298A (es) 2007-05-07
NL300743I2 (xx) 2016-01-26
SI1751276T1 (sl) 2009-06-30
EP1751276B9 (en) 2020-05-27
CY1109036T1 (el) 2014-07-02
JP5562316B2 (ja) 2014-07-30
RS50753B9 (sr) 2020-08-31
NZ552088A (en) 2009-10-30
LU92747I2 (fr) 2015-11-02
UY28905A1 (es) 2005-12-30
CY2015023I1 (el) 2020-05-29
CY2015022I2 (el) 2024-02-16
DK1751276T5 (da) 2020-07-20
ES2321210T9 (es) 2020-11-04
CY2015021I1 (el) 2020-05-29
ATE420949T1 (de) 2009-01-15
NL300744I2 (xx) 2016-01-26
LU92748I2 (fr) 2015-11-02
BRPI0510396A (pt) 2007-11-13
AU2005243488B2 (en) 2011-07-07
PL1751276T3 (pl) 2009-06-30
ME01119B (me) 2013-03-20
EP1751276A1 (en) 2007-02-14
DK1751276T3 (da) 2009-05-18
DE602005012381D1 (de) 2009-03-05
CN1989240A (zh) 2007-06-27
PT1751276E (pt) 2009-02-24
NL300745I1 (xx) 2016-01-26
CY2015021I2 (el) 2023-11-15
JP5006782B2 (ja) 2012-08-22
JP2012061001A (ja) 2012-03-29
CA2561719A1 (en) 2005-11-24
CN103352030A (zh) 2013-10-16
ES2321210T3 (es) 2009-06-03
RS50753B (sr) 2010-08-31
CA2561719C (en) 2015-01-27
NL300744I1 (xx) 2016-01-26
AU2005243488A1 (en) 2005-11-24
HUS1500031I1 (hu) 2019-11-28
CN103352030B (zh) 2018-08-10
AR049176A1 (es) 2006-07-05
NL300745I2 (xx) 2016-01-26
WO2005111201A1 (en) 2005-11-24
DE102004025452A1 (de) 2006-01-19
CY2015022I1 (el) 2020-05-29
EP1751276B1 (en) 2009-01-14
CN1989240B (zh) 2013-07-31
JP2007537740A (ja) 2007-12-27
HUS1500033I1 (hu) 2015-07-28
AR104448A2 (es) 2017-07-19
BRPI0510396B1 (pt) 2020-08-18
KR100908798B1 (ko) 2009-07-22
KR20070012862A (ko) 2007-01-29
NL300743I1 (xx) 2016-01-26
CY2015023I2 (el) 2024-02-16

Similar Documents

Publication Publication Date Title
LU92749I2 (fr) Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2)
BRPI0309631A2 (pt) vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3,e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4
DK1173441T3 (da) 6-alkenyl-, 6-alkynyl- og 6-epoxy-epothilon-derivater, fremgangsmåde til fremstilling af disse samt deres anvendelse i farmaceutiske sammensætninger
DE60035232D1 (de) (S,S)-Reboxetine zur Behandlung von chronischen Erschöpfungssyndrom
NO2012018I2 (no) Canakinumab eller direkte ekvivalenter derav
EP1275666A4 (en) FLUOROPOLYMER COMPRISING A GROUP THAT REACTS TO ACIDS AND PHOTORESIST COMPOSITION WITH CHEMICAL AMPLIFICATION CONTAINING SAID FLUOROPOLYMER
DK1181027T3 (da) Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri
NL1013685A1 (nl) Verknopingsmiddel voor fotolaklaag en fotolaklaagsamenstelling welke deze omvat.
DE60138711D1 (de) Antikörper gegen il-12, zusammensetzungen, verfahren und verwendungen
EP1794329A4 (en) ISOLATES OF PORCINE RESPIRATORY DYSGENESIS SYNDROME (SDRP), AND METHODS OF USE
NO20052363L (no) Interferon-alfa polypeptider og konjugater
FR2869217B1 (fr) Implant glenoidien pour prothese totale d'epaule inversee, et prothese totale d'epaule inversee le comprenant
DE60033043D1 (de) Modifizierte pflanzenviren und deren verwendungsmethoden
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
NL1013684A1 (nl) Verknopingsmiddel voor fotolaklaag, en fotolaklaagsamenstelling welke dezelfde omvat.
DK1749885T3 (da) Infektiøs og svækket kvægdiarévirus
DK1377316T3 (da) Farmaceutisk sammensætning på grundlag af azalider til lokal anvendelse i oftalmologien
DE60120930D1 (de) Neues ethylencopolymer und dessen verwendungen
AU2002365269A8 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
IT1309453B1 (it) Substrato bioartificiale per la realizzazione di tessuti e organianimali, in particolare umani.
IT1313700B1 (it) Composizioni anti-incrostazione e loro impiego nei processi dipolimerizzazione.
WO2006079121A3 (en) Methods of treating disease with glycosylated interferon
EP1590357A4 (en) BICYCLIC CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF INFECTIONS CAUSED BY FLAVIVIRIDAE, SUCH AS HEPATITIS C VIRUSES AND BOVINE VIRAL DIARRHEA
ZA200703762B (en) Mutant porcine reproductive and respiratory syndrome virus
HUP0401182A3 (en) Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other